Management Guidelines for Dermoscopy of Spitz Nevi

Spitz nevi

We know that dermoscopy provides us with more information than is possible with the naked eye. The trick is to understand what the additional information means, and what we should do with it! This is where research on dermoscopy and management guidelines is so important. In this case, we are particularly looking at the management of Spitz nevi. Continue reading “Management Guidelines for Dermoscopy of Spitz Nevi”

Detecting Skin Cancer with Artificial Intelligence

dermatologists

Artificial intelligence has the capacity to revolutionise skin cancer medicine, with multiple programs in development that aid in the early detection of the disease. One such program is Doctor Hazel – a platform that could someday identify cancerous moles with a success rate of 90 percent, provided it attracts enough user submissions.

Still in its infancy, Doctor Hazel was demonstrated earlier this week by a team of engineers at TechCrunch’s Disrupt San Francisco 2017 hackathon. The artificial intelligence program currently identifies cancer at an 85 percent success rate; however, the team has launched a beta and is inviting users to submit their own photos to improve the platform’s performance.

Continue reading “Detecting Skin Cancer with Artificial Intelligence”

Skin Cancer Update with A/Prof Giuseppe Argenziano [September]

skin cancer update

In this skin cancer update video, Associate Professor Giuseppe Argenziano shares the results of a meta-analysis of nevus-associated melanoma. The study asked whether a nevus was a precursor lesion of melanoma.

It found that only a third of melanomas arise from a pre-existing nevus, and the majority of melanomas developed from nondysplastic nevi.

Continue reading “Skin Cancer Update with A/Prof Giuseppe Argenziano [September]”

How to Use the Principle of Hydrodissection in Skin Cancer Surgery

If you perform skin cancer surgery in your practice, you might be interested to see the 1-minute video below with experienced skin cancer doctor Hamilton Ayres. Dr Ayres uses the principle of hydrodissection to remove a lesion on a patient’s ear. The injected fluid helps to separate the tissue planes and facilitates excision. Continue reading “How to Use the Principle of Hydrodissection in Skin Cancer Surgery”

Case discussion: How would you treat this patient? [4 September]

This week we have another engaging case discussion from Dr Slavko Doslo. A 76-year-old patient presented for ROS.

What do you think of this clinical image? What is your impression? (Ignore the adjacent scar).

Continue reading “Case discussion: How would you treat this patient? [4 September]”

[Review] Skin Cancer Summit and Masterclasses 2017

Skin Cancer Summit

Skin Cancer Summit & Masterclasses

26 – 29 July 2017, Brisbane Convention & Exhibition Centre

The 9th Skin Cancer Summit and Masterclasses saw international thought leaders in skin cancer medicine converge in Brisbane to collaborate with GPs from across Australia.

Continue reading “[Review] Skin Cancer Summit and Masterclasses 2017”

Survey on the Use of Teledermoscopy

sun safe

Researchers at the Queensland University of Technology (QUT) and University of Queensland (UQ) are currently undertaking research examining mobile teledermoscopy. The researchers are interested in your opinions about imaging devices and systems used for photographing potential skin cancers, in particular, pigmented lesions that might be suspicious of melanoma. Mobile teledermoscopy could be used for referral, documentation, telediagnosis, discussing the lesion with colleagues, or to obtain a second opinion.

Continue reading “Survey on the Use of Teledermoscopy”

Case discussion: How would you treat this patient? [24 July]

Case discussion - Slavko Doslo

This week’s case discussion is about an elderly man presenting with a cough. On examination, both a basal cell carcinoma and the pigmented lesion shown here were noted.

What is your assessment? Is there anything to be concerned about? Continue reading “Case discussion: How would you treat this patient? [24 July]”

Afatinib Not Recommended Post-CRT for Patients With Squamous Cell Carcinoma of the Head and Neck

melanoma treatment

Data shows that adding afatinib to standard chemoradiation therapy does not improve disease-free survival among patients with squamous cell carcinoma of the head and neck.

Researchers from the Yale Cancer Centre have presented the findings of a randomised, double-blind, placebo-controlled, phase three trial of afatinib as adjuvant therapy after chemoradiation in primary unresected, high- or intermediate-risk, squamous cell cancer of the head and neck patients.

Continue reading “Afatinib Not Recommended Post-CRT for Patients With Squamous Cell Carcinoma of the Head and Neck”

Research into Faster and More Accurate Detection of Melanoma

Melanoma

A breakthrough has been made in the early detection of melanoma, using a compound called fluorinated benzamine. The development could lead to a much faster and more accurate diagnosis of melanoma.

Melanomas can start out as a blemish or mole and often aren’t taken seriously until cancer cells have spread and it’s too late. The fatal disease is difficult to detect as it often grows under the skin before lesions appear suspicious. Continue reading “Research into Faster and More Accurate Detection of Melanoma”